Role of purine metabolism in regulation of signal transduction in human carcinoma cells

Advances in Experimental Medicine and Biology

Volumn 431, Issue , 1998, Pages 401-408

  Weber, George ^a   Shen, Fei ^a   Li, Wei ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGUANOSINE TRIPHOSPHATE; GUANOSINE TRIPHOSPHATE; RIBONUCLEOTIDE REDUCTASE; XANTHINE OXIDASE;

CANCER CELL; CARCINOMA CELL; CONFERENCE PAPER; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH REGULATION; PRIORITY JOURNAL; PURINE METABOLISM; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 0031834483     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5381-6_80     Document Type: Conference Paper

References (12)

1. G. Weber, Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture, Cancer Res. 43:3466-3492 (1983).
2. G. Weber, Enzymology of cancer cells, Parts 1 & 2, New England J. Med. 296:486-493 & 541-551 (1977).
3. G. Weber, N. Prajda, M. Abonyi, K.Y. Look, and G. Tricot, Tiazofurin: Molecular and clinical action, Anticancer Res. 16:3313-3322 (1996).
4. G. Weber, N. Prajda, and R.C. Jackson, Key enzymes of IMP metabolism: Transformation- and proliferation-linked alterations in gene expression, Advan. Enzyme Regul. 14:3-24 (1976).
5. Y. Natsumeda, T. Ikegami, K. Murayama, and G. Weber, De novo guanylate synthesis in the commitment to replication in hepatoma 3924A cells, Cancer Res. 48:507-511(1988).
6. Y. Natsumeda, S. Ohno, H. Kawasaki, Y. Konno, G. Weber, and K. Suzuki, Two distinct cDNAs for human IMP dehydrogenase, J. Biol. Chem. 265:5292-5295 (1990).
7. M. Nagai, Y. Natsumeda, and G. Weber, Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells, Cancer Res. 52:258-261 (1992).
8. M.S. Lui, M.A. Faderan, J.J. Liepnieks, Y. Natsumeda, E. Olah, H.N. Jayaram, and G. Weber, Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-β-D-ribofuranosyhhiazole-4-carboxamide), J. Biol. Chem. 259:5078-5082 (1984).
9. E. Olah, Y. Natsumeda, T. Ikegami, Z. Kote, M. Horanyi, J. Szelenyi, E. Paulik, T. Kremmer, S.R. Hollan, J. Sugar, and G. Weber, Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells, Proc. Natl. Acad. Sci. U.S.A. 85:6533-6537 (1988).
10. M. Vitale, L. Zamai, E. Falcieri, G. Zauli, P. Gobbi, S. Santi, C. Cinti, and G. Weber, IMP dehydrogenase inhibitor, tiazofurin, induces apoptosis in K562 human erythroleukemia cells, Cytometry 30:61-66 (1997).
11. G. Tricot, H. N. Jayaram, G. Weber, and R. Huffman, Tiazofurin: biological effects and clinical uses, Intl. J. Cell Cloning 8:161-170 (1990).
12. D.G. Wright, M.S. Boosalis, L.J. Oshry, and K. Waraska, Tiazofurin effects on IMP dehydrogenase activity and expression in the leukemia cells of patients with CML blast crisis, Anticancer Res. 16:3349-3354 (1996).